Which companies developing cancer drugs are attractive takeover targets? Seeking Alpha analysts offer their picks. Read more here.

Merck MRK and Pfizer PFE are leading pharmaceutical companies with strong product and pipeline portfolios in oncology. Both companies also have presences in vaccines, neuroscience, and immunology.

Imagene is the Innovation award winner in the Precision Oncology category in the 2025 Pharmaceutical Excellence Awards.

Pharmaceutical companies are making billions on treatments that can sometimes overpromise and underdeliver for terminal cases ...

Companies remain exposed to heightened risks between the world’s largest markets and are cautious of the stability of ...

Leerink Partners previews the drugs likely to be subject to the Inflation Reduction Act’s next price negotiations as the ...

Introduction Oncology drugs are medications used to prevent or treat cancer. These include chemotherapy, targeted therapy, immunotherapy, and h ...

Here we highlight a subset of our preferred stocks from the screener. Overview: The Oncology Institute, Inc. is a U.S.-based company offering a range of medical oncology services with a market cap ...

Stocks of cancer treatment developers will be moving into the spotlight later this week when the annual meeting of the ...

Discover seven lung cancer companies advancing promising candidates through the clinic, from viral immunotherapies to ...

The medium-sized biopharma is showing off new results from dordaviprone and Zepzelca, both of which were acquired through ...